Decreased screening rates and fear of COVID has delayed cancer diagnoses for many, delaying treatment and possibly worsening outcomes for cancer patients. Pandemic related reduction of cancer research and treatment threatens to derail future efforts to find more effective detection and treatment methods. Similar to COVID-19, the disparities have disproportionately impacted communities of color.
Author: Jill Hopke
Jill Hopke is an associate professor of Journalism at DePaul University and a Public Voices Fellow with The OpEd Project.